Membreve, Janejane .

HRN: 22-38-06  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/11/2023
CEFUROXIME 1.5GM (VIAL)
01/11/2023
01/11/2023
IVT
1.5 Gms
Q8 X 3 Doses
LTCS
Waiting Final Action 
01/12/2023
CEFUROXIME 500MG (TAB)
01/12/2023
01/19/2023
ORAL
500
BID
LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: